Stockreport

Theravance Biopharma Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]

Theravance Biopharma, Inc. - Ordinary Shares  (TBPH) 
Last theravance biopharma, inc. - ordinary shares earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.theravance.com/investor-relations
PDF Net loss: US$56.4m (loss widened by 2.2% from FY 2023). US$1.16 loss per share (further deteriorated from US$1.00 loss in FY 2023). NasdaqGM:TBPH Earnings and Reven [Read more]